# A Study in Subjects With Retinal Detachment

> **NCT00210067** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 14 (actual)

## Conditions studied

- Retinal Detachment

## Interventions

- **DRUG:** denufosol tetrasodium (INS37217) Intravitreal Injection

## Key facts

- **NCT ID:** NCT00210067
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-05
- **Primary completion:** 2002-06
- **Final completion:** 2002-06
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2015-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00210067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00210067, "A Study in Subjects With Retinal Detachment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00210067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*